glp 1 agonist heart disease GLP-1RA in Different HFpEF Phenotypes GLP-1 Receptor Agonists in Heart
Description
By 2030, over 30 million U.S
It is clinical suitability, safety and long-term outcomes
Thus, in overweight/obese women with PCOS, combination treatment is more effective than metformin alone by improving insulin sensitivity, with tolerable short-term side effects (201)
They are not fertility medications and do not replace hormonal treatments when those are needed
The introduction of an injectable GLP-1 has opened up new possibilities for patients with type 2 diabetes and obesity
